News
NICE allows early use of SGLT-2 inhibitors for diabetes patients to protect heart, kidneys
NICE analysis found that introducing SGLT-2 medicines earlier in the treatment pathway helps reduce the risk of heart attacks, strokes and kidney problems
Feb 20, 2026







